In part 2, Harini Bupathi, Esq, dives deeper into PBMs’ goals behind pharmacy audits and how that could all change with recent reform measures.
Total Pharmacy
Latest News
Total Pharmacy Podcasts
All News
Advertisement
As health care spending and polypharmacy increase, researchers are exploring new ways to deprescribe medications, looking to pharmacists to fill in a gap.
Sponsored Content
Community pharmacies have become one of the most accessible points of care for patients, especially in rural and underserved communities.
Harini Bupathi, Esq, discusses the basis of PBM audits, why they exist, and how pharmacies can anticipate them.
Independent pharmacies combat daily drug shortages with smarter inventory monitoring and diversified suppliers.
With social determinants of health impacting patient outcomes, researchers assess the viability of community pharmacy partnerships for addressing atrial fibrillation.
In a recent PSG-sponsored webinar, experts present on the growing push toward new-wave pharmacy benefit managers models in pharmacy benefits design.
As clinical roles expand, the need for robust pharmacy infrastructure to streamline workflows and ensure medication access has never been more critical.
This episode explores the true price of commitment to a dream or vision, explaining how anything less than full dedication can lead to failure and why small wins are essential for perseverance.
With insights from executives working around the clock to advance the pharmacy profession, our experts predicted what the landscape will look like following the Consolidated Appropriations Act of 2026.
Advertisement
Featuring pharmacist and entrepreneur Sam Maddula, PharmD, this episode explores some key legislative and regulatory insights regarding owning and operating a pharmacy business.
Represented by Frier Levitt, multiple hospital systems filed lawsuits on May 21, 2026, targeting a variety of entities existing under CVS Health.
This month’s event will explore policy, people, and profitability, and how pharmacy businesses can transform these factors toward actionable solutions.
In this episode, host Taylor Watterson, PharmD, PhD, provides a deeper look into workplace fatigue and the metrics used to calculate and facilitate it.
Two separate bills were marked up in House committees last week and were officially advanced to potentially move additional PBM reform into law.
The proposed bill would force pharmacy benefit managers to act on the interests of pharmacies rather than their own companies.
From PBM reform and AI to burnout and closures, Tom DePietro, PharmD, addresses the current state of independent pharmacy.
In part 2, Tom DePietro, PharmD, explores emerging topics of interest within community pharmacy, including AI, PBMs, and the industry’s evolving nature.
Between clinical initiatives, educational strategies, and regulatory frameworks, researchers explore PGx services integration.
From PBM reform designed to benefit pharmacies to closures impacting the greater public health sector, Tom DePietro, PharmD, discusses current developments in community pharmacy.
Despite a myriad of data and news releases about the growing prominence of AI in pharmacy practice, several knowledge and acceptance gaps persist.
This episode explores the differences between behavior that is caught rather than taught, explaining how leadership can be a learned skill if properly approached.
With value-based care initiatives on the rise in the US health care system, one partnership in Ohio is showing early signs of significant success.
In part 2, Kevin Day, PharmD, breaks down the Pharmacy Quality Rewards Program and its push toward value-based care in pharmacy practice.
Kevin Day, PharmD, provides insight into his role in the Pharmacist Quality Rewards Program and what it’s doing for patients in his community.
Utilizing colleges and schools of pharmacy, researchers explorensolutions to the growing challenges affecting community pharmacy.
Advertisement
Advertisement
Trending on Drug Topics
1
Metformin Cuts Long COVID Risk by Half in New ACTIV-6 Trial Results
2
FDA Approves Utebzi as First Oral Carbapenem for Complicated UTIs
3
Oral Orforglipron for Obesity Management
4
How Will Emerging AI Impact the Pharmacy Benefit Manager Space?
5